394 related articles for article (PubMed ID: 32664454)
1. Approaching Sex Differences in Cardiovascular Non-Coding RNA Research.
Jusic A; Salgado-Somoza A; Paes AB; Stefanizzi FM; Martínez-Alarcón N; Pinet F; Martelli F; Devaux Y; Robinson EL; Novella S; On Behalf Of The Eu-CardioRNA Cost Action
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664454
[TBL] [Abstract][Full Text] [Related]
2. Non-coding RNAs: The key detectors and regulators in cardiovascular disease.
Zhu L; Li N; Sun L; Zheng D; Shao G
Genomics; 2021 Jan; 113(1 Pt 2):1233-1246. PubMed ID: 33164830
[TBL] [Abstract][Full Text] [Related]
3. Phenotype-genotype network construction and characterization: a case study of cardiovascular diseases and associated non-coding RNAs.
Wu R; Lin Y; Liu X; Zhan C; He H; Shi M; Jiang Z; Shen B
Database (Oxford); 2020 Jan; 2020():. PubMed ID: 31942979
[TBL] [Abstract][Full Text] [Related]
4. Systematic review regulatory principles of non-coding RNAs in cardiovascular diseases.
Li Y; Huo C; Pan T; Li L; Jin X; Lin X; Chen J; Zhang J; Guo Z; Xu J; Li X
Brief Bioinform; 2019 Jan; 20(1):66-76. PubMed ID: 28968629
[TBL] [Abstract][Full Text] [Related]
5. Illuminating the Molecular Intricacies of Exosomes and ncRNAs in Cardiovascular Diseases: Prospective Therapeutic and Biomarker Potential.
Khan FB; Uddin S; Elderdery AY; Goh KW; Ming LC; Ardianto C; Palakot AR; Anwar I; Khan M; Owais M; Huang CY; Daddam JR; Khan MA; Shoaib S; Khursheed M; Reshadat S; Khayat Kashani HR; Mirza S; Khaleel AA; Ayoub MA
Cells; 2022 Nov; 11(22):. PubMed ID: 36429092
[TBL] [Abstract][Full Text] [Related]
6. Non-coding RNAs regulating mitochondrial function in cardiovascular diseases.
Ao X; Ding W; Li X; Xu Q; Chen X; Zhou X; Wang J; Liu Y
J Mol Med (Berl); 2023 May; 101(5):501-526. PubMed ID: 37014377
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in targeted delivery of non-coding RNA-based therapeutics for atherosclerosis.
Li X; Qi H; Cui W; Wang Z; Fu X; Li T; Ma H; Yang Y; Yu T
Mol Ther; 2022 Oct; 30(10):3118-3132. PubMed ID: 35918894
[TBL] [Abstract][Full Text] [Related]
8. Role of Non-Coding RNA of Human Platelet in Cardiovascular Disease.
Inzulza-Tapia A; Alarcón M
Curr Med Chem; 2022; 29(19):3420-3444. PubMed ID: 34967288
[TBL] [Abstract][Full Text] [Related]
9. Non-coding RNAs in diabetes mellitus and diabetic cardiovascular disease.
Li C; Wang D; Jiang Z; Gao Y; Sun L; Li R; Chen M; Lin C; Liu D
Front Endocrinol (Lausanne); 2022; 13():961802. PubMed ID: 36147580
[TBL] [Abstract][Full Text] [Related]
10. ncRNAs in Therapeutics: Challenges and Limitations in Nucleic Acid-Based Drug Delivery.
Hueso M; Mallén A; Suñé-Pou M; Aran JM; Suñé-Negre JM; Navarro E
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769025
[TBL] [Abstract][Full Text] [Related]
11. RNA (Epi)genetics in cardiovascular diseases.
Elia L; Condorelli G
J Mol Cell Cardiol; 2015 Dec; 89(Pt A):11-6. PubMed ID: 26205296
[TBL] [Abstract][Full Text] [Related]
12. Targeted basic research to highlight the role of estrogen and estrogen receptors in the cardiovascular system.
Dworatzek E; Mahmoodzadeh S
Pharmacol Res; 2017 May; 119():27-35. PubMed ID: 28119050
[TBL] [Abstract][Full Text] [Related]
13. Clinical value of non-coding RNAs in cardiovascular, pulmonary, and muscle diseases.
Bonnet S; Boucherat O; Paulin R; Wu D; Hindmarch CCT; Archer SL; Song R; Moore JB; Provencher S; Zhang L; Uchida S
Am J Physiol Cell Physiol; 2020 Jan; 318(1):C1-C28. PubMed ID: 31483703
[TBL] [Abstract][Full Text] [Related]
14. Exosomal non-coding RNAs (Exo-ncRNAs) in cardiovascular health.
Jaquenod De Giusti C; Santalla M; Das S
J Mol Cell Cardiol; 2019 Dec; 137():143-151. PubMed ID: 31669445
[TBL] [Abstract][Full Text] [Related]
15. Genetics meets epigenetics: Genetic variants that modulate noncoding RNA in cardiovascular diseases.
Calore M; De Windt LJ; Rampazzo A
J Mol Cell Cardiol; 2015 Dec; 89(Pt A):27-34. PubMed ID: 26546166
[TBL] [Abstract][Full Text] [Related]
16. Non-coding RNAs: the "dark matter" of cardiovascular pathophysiology.
Iaconetti C; Gareri C; Polimeni A; Indolfi C
Int J Mol Sci; 2013 Oct; 14(10):19987-20018. PubMed ID: 24113581
[TBL] [Abstract][Full Text] [Related]
17. Prospective Advances in Non-coding RNAs Investigation.
Jan MI; Ali T; Ishtiaq A; Mushtaq I; Murtaza I
Adv Exp Med Biol; 2020; 1229():385-426. PubMed ID: 32285426
[TBL] [Abstract][Full Text] [Related]
18. Non-coding RNA-mediated modulation of ferroptosis in cardiovascular diseases.
Liu Y; Ding W; Wang J; Ao X; Xue J
Biomed Pharmacother; 2023 Aug; 164():114993. PubMed ID: 37302320
[TBL] [Abstract][Full Text] [Related]
19. Strategies and challenges for non-viral delivery of non-coding RNAs to the heart.
Vilaça A; de Windt LJ; Fernandes H; Ferreira L
Trends Mol Med; 2023 Jan; 29(1):70-91. PubMed ID: 36371335
[TBL] [Abstract][Full Text] [Related]
20. Noncoding RNAs in Cardiovascular Disease: Pathological Relevance and Emerging Role as Biomarkers and Therapeutics.
Gangwar RS; Rajagopalan S; Natarajan R; Deiuliis JA
Am J Hypertens; 2018 Jan; 31(2):150-165. PubMed ID: 29186297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
